Click on headlines below to download research

Executive interview
Oxford Biomedica – executive interview | 24/02/2021

Why are investors buying into Oxford Biomedica (LN:OXB)? In this interview, BBC broadcaster Vivienne Parry OBE asks CEO John Dawson why Oxford Biomedica…

Vector innovation key to cell and gene evolution
Oxford Biomedica | 05/10/2020

Oxford Biomedica (OXB) is a pioneer and global leader in the development and manufacture of commercial-scale lentiviral vectors (LVVs), a critical component…